Transparency mandate embedded into the proposed amendments to the International Health Regulations: Rationales underpinning the proposed Bureau’s text

On 17 April 2024, the World Health Organization (WHO) published the Proposed Bureau’s text in advance of the 8th meeting of the Working Group on Amendments to the International Health Regulations (2005) (WGIHR) which meets from 22–26 April 2024. Accompanying… Continue Reading

The Article 13 Express: WHA 77.1 – WHO Pandemic Agreement

On Wednesday, 17 April 2024 at 15:25 CEST, the WHO secretariat circulated an advance, unedited English version of the proposed draft WHO Pandemic Agreement; the WHO secretariat also circulated the accompanying draft resolution, WHA77.1 WHO Pandemic Agreement. For KEI’s analysis… Continue Reading

Colombia’s birthday present to the World Trade Organization: a proposal to review the implementation of the TRIPS Agreement: Article 71.1

On 15 April 2024, the World Trade Organization (WTO) published a document, IP/C/W/712, entitled, Review of the implementation of the TRIPS Agreement: Article 71.1; this date marks 30 years after the establishment of the WTO. Colombia’s proposal can be found… Continue Reading

Request for CMS to provide a Bayh-Dole Section 202 license and a 28 USC 1498 authorization and consent to use three patents listed in the FDA Orange Book for the cancer drug enzalutamide

Letter from KEI, UACT and UAEM to Chiquita White Brooks-Lasure, Administrator of the Office of the Administrator, Centers for Medicare and Medicaid Services, at HHS, asking that CMS to provide a Bayh-Dole Section 202 license and a 28 USC 1498… Continue Reading

KEI Comments to the NIH on Exclusive License to UK Firm Poolbeg Pharma

On April 8, 2024, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the prospective grant of an exclusive license to Poolbeg Pharma Limited, a UK-based company. The license concerns, “Adoptive T Cell Therapy Products… Continue Reading